← All trials
NCT01717248
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 1, 2013
- Primary completion
- Jun 1, 2013
- Completion date
- Jun 1, 2013
- First posted
- —
- Last posted
- —
- Enrollment
- 29
- Arms / groups
- 1 / —
- Source
- AACT · pre-existing
Sponsors
- La Jolla Pharmaceutical CompanyLead sponsor
- Denver Nephrologists, P.C.Overall official - principal investigator
- Southwest Clinical Research Institute, LLCOverall official - principal investigator
- California Institute of Renal Research, Inc.Overall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.